4 Matching Annotations
  1. Aug 2022
    1. Thuluva, S., Paradkar, V., Turaga, K., Gunneri, S., Yerroju, V., Mogulla, R., Kyasani, M., Manoharan, S. K., Medigeshi, G., Singh, J., Shaman, H., Singh, C., & Rao, A. V. (2022). Selection of optimum formulation of RBD-based protein sub-unit covid19 vaccine (Corbevax) based on safety and immunogenicity in an open-label, randomized Phase-1 and 2 clinical studies (p. 2022.03.08.22271822). medRxiv. https://doi.org/10.1101/2022.03.08.22271822

  2. Jun 2022
  3. bafybeiccxkde65wq2iwuydltwmfwv733h5btvyrzqujyrt5wcfjpg4ihf4.ipfs.dweb.link bafybeiccxkde65wq2iwuydltwmfwv733h5btvyrzqujyrt5wcfjpg4ihf4.ipfs.dweb.link
  4. May 2022
  5. Oct 2021